1. Home
  2. Stocks
  3. Iolcp Share Price
  • Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • IOL Chemicals and Pharmaceuticals Share Price

    Small Cap
    ₹486.45
    + 4.55 (0.94%)
    21 September, 2024 01:29 BSE: 524164 NSE: IOLCP ISIN: INE485C01011

    Start SIP in IOL Chemicals and Pharmaceuticals

    Start SIP

    IOL Chemicals and Pharmaceuticals Performance

    Day Range

    • Low 481
    • High 492
    ₹ 486

    52 Week Range

    • Low 331
    • High 538
    ₹ 486
    • Open Price485
    • Previous Close482
    • Volume536013

    IOL Chemicals and Pharmaceuticals Chart

    • Over 1 Month + 21.26%
    • Over 3 Month + 19.95%
    • Over 6 Month + 20.57%
    • Over 1 Year -3.02%

    IOL Chemicals and Pharmaceuticals Key Statistics

    P/E Ratio 24.1
    PEG Ratio -1.1
    Market Cap Cr
    Price to Book Ratio 1.8
    EPS 23.1
    Dividend 1
    Relative Strength Index 56.79
    Money Flow Index 86.52
    MACD Signal 17.86
    Average True Range 24.09

    Iol Chemicals And Pharmaceuticals Investment Rating

    • Master Rating:

    • Iol Chemicals & Pharms. has an operating revenue of Rs. 2,071.99 Cr. on a trailing 12-month basis. An annual revenue de-growth of -4% needs improvement, Pre-tax margin of 9% is okay, ROE of 8% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 10% and 15% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -10% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 18 which is a POOR score indicating inconsistency in earnings, a RS Rating of 39 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 90 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    IOL Chemicals and Pharmaceuticals Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 502504520545563587
    Operating Expenses Qtr Cr 452454476481490491
    Operating Profit Qtr Cr 515044647396
    Depreciation Qtr Cr 171616161412
    Interest Qtr Cr 234445
    Tax Qtr Cr 10109131522
    Net Profit Qtr Cr 302823384665
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 2,1632,243
    Operating Expenses Annual Cr 1,9011,991
    Operating Profit Annual in Cr 232227
    Depreciation Cr 6346
    Interest Annual Cr 1616
    Tax Annual Cr 4750
    Net Profit Annual Cr 135140
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 291123
    Cash from Investing Activity Annual Cr -192-119
    Cash from Financing Annual Activity Cr -93-4
    Net Cash Flow Annual Cr 70
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,6111,507
    Fixed Assets Annual Cr 1,034841
    Total Non Current Assets Annual Cr 1,1241,102
    Total Current Assets Annual Cr 1,119919
    Total Assets Annual Cr 2,2442,021
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 274257
    ROE Annual % 89
    ROCE Annual % 1213
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1211
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 502504520545563587
    Operating Expenses Qtr Cr 451454476481491492
    Operating Profit Qtr Cr 515044647395
    Depreciation Qtr Cr 171616161412
    Interest Qtr Cr 234445
    Tax Qtr Cr 10109131522
    Net Profit Qtr Cr 302823384665
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 2,1632,243
    Operating Expenses Annual Cr 1,9021,991
    Operating Profit Annual in Cr 231226
    Depreciation Cr 6346
    Interest Annual Cr 1616
    Tax Annual Cr 4750
    Net Profit Annual Cr 134139
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 290122
    Cash from Investing Activity Annual Cr -191-120
    Cash from Financing Annual Activity Cr -93-4
    Net Cash Flow Annual Cr 6-2
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,6121,508
    Fixed Assets Annual Cr 1,034841
    Total Non Current Assets Annual Cr 1,1251,102
    Total Current Assets Annual Cr 1,120920
    Total Assets Annual Cr 2,2442,022
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 274257
    ROE Annual % 89
    ROCE Annual % 1213
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1211
    Invest in IOL Chemicals and Pharmaceuticals

    IOL Chemicals and Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹486.45
    + 4.55 (0.94%)
    pointer
    • Bullish Moving Average
    • ___
    • 12
    • Bearish Moving Average
    • ___
    • 4
    • 20 Day
    • ₹473.71
    • 50 Day
    • ₹447.39
    • 100 Day
    • ₹429.54
    • 200 Day
    • ₹419.91
    • 20 Day
    • ₹471.23
    • 50 Day
    • ₹438.52
    • 100 Day
    • ₹413.83
    • 200 Day
    • ₹418.08

    IOL Chemicals and Pharmaceuticals Resistance and Support

    PIVOT
    ₹486.55
    Resistance
    First Resistance 492.15
    Second Resistance 497.85
    Third Resistance 503.45
    RSI 56.79
    MFI 86.52
    MACD Single Line 17.86
    MACD 17.83
    Support
    First Support 480.85
    Second Support 475.25
    Third Supoort 469.55

    IOL Chemicals and Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 592,961 18,280,988 30.83
    Week 1,323,048 37,217,346 28.13
    1 Month 1,696,109 45,336,996 26.73
    6 Month 622,009 19,972,717 32.11

    IOL Chemicals and Pharmaceuticals Result Highlights

    IOL Chemicals and Pharmaceuticals Synopsis

    NSE-Chemicals-Specialty

    Iol Chemicals And Ph is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 2132.79 Cr. and Equity Capital is Rs. 58.71 Cr. for the Year ended 31/03/2024. IOL Chemicals and Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 29/09/1986 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L24116PB1986PLC007030 and registration number is 007030.
    Market Cap 2,829
    Sales 2,072
    Shares in Float 3.05
    No of funds 47
    Yield 1.04
    Book Value 1.76
    U/D Vol ratio 2.8
    LTDebt / Equity
    Alpha -0.13
    Beta 1.14

    IOL Chemicals and Pharmaceuticals Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 48.19%48.19%48.19%48.19%
    Mutual Funds 0.09%0.08%0.06%0.05%
    Foreign Portfolio Investors 1.39%1.4%2.18%2.33%
    Individual Investors 31.48%30.98%30.64%30.28%
    Others 18.85%19.35%18.93%19.15%

    IOL Chemicals and Pharmaceuticals Management

    Name Designation
    Mr. Rajender Mohan Malla Chairman & Ind.Director
    Mr. Varinder Gupta Managing Director
    Mr. Vikas Gupta Joint Managing Director
    Mr. Kushal Kumar Rana Director - Works
    Dr.(Mrs.) Sandhya Mehta Independent Director
    Mr. Harpal Singh Independent Director
    Mr. Sharad Tyagi Independent Director
    Mr. Abhiraj Gupta Executive Director

    IOL Chemicals and Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    IOL Chemicals and Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2024-08-09 Quarterly Results
    2024-05-14 Audited Results
    2024-02-06 Quarterly Results & Interim Dividend
    2023-11-08 Quarterly Results
    2023-08-09 Quarterly Results
    Date Purpose Remarks
    2024-02-16 INTERIM Rs.5.00 per share(50%)Interim Dividend
    2023-02-17 INTERIM Rs.4.00 per share(40%)Interim Dividend
    2022-02-16 INTERIM Rs.4.00 per share(40%)Interim Dividend

    IOL Chemicals and Pharmaceuticals MF Shareholding

    Name Amount(cr)
    Motilal Oswal Nifty Microcap 250 Index Fund Regular Growth 1,487
    Groww Nifty Total Market Index Fund Regular Growth 219
    Bandhan Nifty Total Market Index Fund Regular Growth 35

    IOL Chemicals and Pharmaceuticals FAQs

    What is Share Price of IOL Chemicals and Pharmaceuticals ?

    IOL Chemicals and Pharmaceuticals share price is ₹486 As on 21 September, 2024 | 01:15

    What is the Market Cap of IOL Chemicals and Pharmaceuticals ?

    The Market Cap of IOL Chemicals and Pharmaceuticals is ₹2855.7 Cr As on 21 September, 2024 | 01:15

    What is the P/E ratio of IOL Chemicals and Pharmaceuticals ?

    The P/E ratio of IOL Chemicals and Pharmaceuticals is 24.1 As on 21 September, 2024 | 01:15

    What is the PB ratio of IOL Chemicals and Pharmaceuticals ?

    The PB ratio of IOL Chemicals and Pharmaceuticals is 1.8 As on 21 September, 2024 | 01:15

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     
    footer_form

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of ₹10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.